Compare Cronos Group (CRON) With Other Cannabis Stocks
Head-to-head stock comparisons across price, valuation, financials, and growth metrics
Cronos Group (CRON)
$3.35
-0.89%
$1.23B
LP
LP Sector Peers
All LP cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.
| Ticker | Name | Price | Change % | MCap |
|---|---|---|---|---|
| TLRY | Tilray Brands | $2.69 | -2.89% | $397.5M |
| SNDL | SNDL Inc | $1.29 | -0.77% | $339.7M |
| VFF | Village Farms International | $2.58 | -0.39% | $316.1M |
| CGC | Canopy Growth | $0.67 | -1.81% | $282.5M |
| CBWTF | Auxly Cannabis Group | $2.56 | +3.44% | $239.6M |
| HITI | High Tide Inc | $2.69 | +0.75% | $232.0M |
| ACB | Aurora Cannabis | $4.08 | -1.69% | $226.2M |
| OGI | Organigram Holdings | $0.96 | +1.71% | $131.3M |
| LOVFF | Cannara Biotech | $1.43 | -0.28% | $92.4M |
| DBCCF | Decibel Cannabis Co | $1.33 | +2.15% | $34.8M |
| VVIVF | Vivo Cannabis | $0.17 | -2.27% | $28.9M |
| AVTBF | Avant Brands | $0.36 | -4.08% | $19.6M |
| MEDIF | MediPharm Labs | $0.0485 | 0.00% | $18.0M |
| ROMJF | Rubicon Organics | $0.27 | -4.90% | $13.3M |
| GWAYF | Greenway Greenhouse Cannabis | $0.0620 | +0.16% | $8.2M |
| CLCFF | Christina Lake Cannabis | $0.0185 | +0.54% | $2.3M |
| LFSWF | Lifeist Wellness | $0.0268 | +0.75% | $1.0M |
Top Matchups by Market Cap
Companies closest to Cronos Group in market capitalization — the most meaningful head-to-head comparisons.
Turning Point Brands
MCap: $1.35B
Innovative Industrial Properties
MCap: $1.46B
Green Thumb Industries
MCap: $1.54B
AdvisorShares Pure US Cannabis ETF
MCap: $781.2M
Tilray Brands
MCap: $397.5M
Cross-Sector Comparisons
Top cannabis companies outside the LP sector. Compare across different business models and market segments.
Comparing CRON in the Cannabis Market
Cronos Group (CRON) is a licensed cannabis producer (LP)trading at $3.35 per share with a market capitalization of $1.23B. Among its LP peers, CRON ranks first by market cap, with trailing twelve-month revenue of $179.1M and a gross margin of 45.9%. The stock has moved -0.89% in the current session, trading on the NASDAQ exchange.
When comparing CRON against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (6.9x), revenue growth (+37.46% YoY), and balance sheet strength (cash of $467.0M; total debt not reported). The comparison tables above allow you to evaluate Cronos Group relative to 17 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.
Frequently Asked Questions
How does CRON compare to other LP stocks?+
What is CRON's biggest competitor?+
Is CRON overvalued compared to its peers?+
Which cannabis stock has better margins than CRON?+
Can I compare CRON to stocks in other cannabis sectors?+
All CRON Comparisons
Every available head-to-head comparison for Cronos Group.
Related Pages
Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.